C-Y Li Selected Research

C-Y Li Research Topics

Disease

6	Neoplasms (Cancer) 02/2017 - 10/2002
5	Vitiligo 10/2015 - 05/2012
3	Stomach Neoplasms (Stomach Cancer) 02/2017 - 11/2016
2	Neuralgia (Stump Neuralgia) 01/2019 - 04/2013
2	Tuberculosis (Tuberculoses) 01/2018 - 09/2009
2	Melanoma (Melanoma, Malignant) 06/2004 - 10/2002
1	Cerebral Hemorrhage 01/2022
1	Stroke (Strokes) 01/2022
1	Ischemic Stroke 01/2022
1	Hemorrhage 01/2022
1	COVID-19 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Ischemia 01/2020
1	Cerebral Infarction 01/2020
1	Inflammation (Inflammations) 08/2019
1	Arthritis (Polyarthritis) 08/2019
1	Rheumatoid Arthritis 08/2019
1	Body Weight (Weight, Body) 01/2019
1	Mononeuropathies (Mononeuritis Multiplex) 01/2019
1	Hypothyroidism 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2018
1	Triple Negative Breast Neoplasms 01/2018
1	Lymphatic Metastasis 02/2017
1	Cognitive Dysfunction 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 12/2015
1	Male Infertility (Male Sterility) 10/2015
1	Azoospermia 10/2015
1	Adenoid Cystic Carcinoma (Cylindroma) 07/2015
1	Fibrosis (Cirrhosis) 01/2014
1	Hyperthyroidism 01/2014
1	Infections 01/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2013
1	Adenocarcinoma of Lung 06/2013
1	Hyperalgesia 04/2013
1	Breast Neoplasms (Breast Cancer) 04/2013
1	Hypersensitivity (Allergy) 04/2013
1	Peripheral Nerve Injuries 04/2013
1	Disease Progression 03/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2012

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2004
4	DNA (Deoxyribonucleic Acid)IBA 08/2015 - 10/2002
3	Pharmaceutical PreparationsIBA 08/2019 - 06/2013
3	MicroRNAs (MicroRNA)IBA 01/2018 - 11/2016
2	RNA (Ribonucleic Acid)IBA 01/2020 - 08/2019
2	Biological ProductsIBA 11/2016 - 06/2004
2	HomocysteineIBA 10/2015 - 05/2014
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 10/2015 - 05/2014
2	Monophenol Monooxygenase (Tyrosinase)IBA 10/2015 - 06/2004
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2020
1	Type 1 Galanin ReceptorIBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	Adenosine Triphosphatases (ATPase)IBA 01/2019
1	protein kinase modulatorIBA 01/2019
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2019
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2019
1	Propylthiouracil FDA Link 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2018
1	CarbonIBA 01/2018
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2018
1	Glycerol (Glycerine)FDA LinkGeneric 01/2018
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2018
1	Aminosalicylic Acid (Rezipas)FDA Link 01/2018
1	Streptomycin (Streptomycin Sulfate)FDA Link 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	Levofloxacin (Levaquin)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 02/2017
1	Long Noncoding RNAIBA 11/2016
1	Remifentanil (Ultiva)FDA Link 01/2016
1	Propofol (Diprivan)FDA LinkGeneric 01/2016
1	Phosphates (Orthophosphate)IBA 12/2015
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2015
1	Melanins (Melanin)IBA 10/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015
1	Pyrimidine DimersIBA 08/2015
1	Codon (Codons)IBA 08/2015
1	Fibronectins (Fibronectin)IBA 07/2015
1	Serum AlbuminIBA 01/2014
1	Peptides (Polypeptides)IBA 08/2013
1	AgglutininsIBA 06/2013
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 04/2013
1	Calcium Channels (Calcium Channel)IBA 04/2013
1	Ondansetron (Zofran)FDA LinkGeneric 04/2013
1	Toll-Like Receptor 4IBA 04/2013
1	HLA-Bw4 antigenIBA 03/2013
1	25-hydroxyvitamin DIBA 10/2012
1	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2012
1	hydroxide ionIBA 10/2012
1	methyl 4-azidophenylacetimidate (APAI)IBA 10/2012

Therapy/Procedure

6	Therapeutics 01/2022 - 03/2013
1	Sutures (Suture) 01/2020
1	Ligation 01/2019
1	Activities of Daily Living (ADL) 01/2018
1	Aftercare (After-Treatment) 01/2018
1	Phototherapy (Light Therapy) 08/2015
1	Highly Active Antiretroviral Therapy (HAART) 01/2014
1	Injections 04/2013